LUHMES 人多巴胺能神經(jīng)元前體細(xì)胞系 / BioVector? LUHMES Human Dopaminergic Neuronal Precursor Cell Line
- 價(jià) 格:¥49950
- 貨 號(hào):BioVector? LUHMES
- 產(chǎn) 地:北京
- BioVector NTCC典型培養(yǎng)物保藏中心
- 聯(lián)系人:Dr.Xu, Biovector NTCC Inc.
電話:400-800-2947 工作微信:1843439339 (QQ同號(hào))
手機(jī):18901268599
地址:北京
- 已注冊
BioVector? LUHMES 人多巴胺能神經(jīng)元前體細(xì)胞系 / BioVector? LUHMES Human Dopaminergic Neuronal Precursor Cell Line
通用定義 / General Definition:BioVector? LUHMES(Lund Human Mesencephalic)是一種源自人類中腦(Mesencephalon)的多巴胺能神經(jīng)元前體細(xì)胞系。該細(xì)胞系通過 v-myc 基因的四環(huán)素受控表達(dá)實(shí)現(xiàn)永生化。LUHMES 的核心優(yōu)勢在于其高度的可塑性:在添加特定因子(如 GDNF 和 dibutyryl cAMP)并下調(diào) v-myc 表達(dá)后,它們可以迅速、高效地分化為具有成熟電生理活性的多巴胺能神經(jīng)元。它是研究帕金森?。≒D)、神經(jīng)毒理學(xué)、多巴胺代謝及神經(jīng)保護(hù)藥物篩選的理想人源細(xì)胞模型。
BioVector? LUHMES (Lund Human Mesencephalic) is a human dopaminergic neuronal precursor cell line derived from the human mesencephalon. The line was immortalized via the tetracycline-regulated expression of the v-myc oncogene. The primary advantage of LUHMES is its high plasticity: upon treatment with specific factors (such as GDNF and dibutyryl cAMP) and the downregulation of v-myc, these cells differentiate rapidly and efficiently into dopaminergic neurons with mature electrophysiological properties. It is a premier human model for studying Parkinson's Disease (PD), neurotoxicology, dopamine metabolism, and neuroprotective drug screening.
BioVector? LUHMES 技術(shù)說明書 (Technical Datasheet)
中文版說明書 (Chinese Datasheet)
1. 產(chǎn)品基本信息
產(chǎn)品名稱: BioVector? LUHMES 人中腦神經(jīng)前體細(xì)胞
組織來源: 人胚胎中腦 (Human Embryonic Mesencephalon)
生長特性: 貼壁生長(需包被)
分化潛能: 可誘導(dǎo)分化為成熟多巴胺能神經(jīng)元(表達(dá)抗酪氨酸羥化酶 TH)
細(xì)胞形態(tài): 增殖期呈雙極性或小多角形;分化后具有長神經(jīng)突起
2. 培養(yǎng)條件
基礎(chǔ)培養(yǎng)基: BioVector? Advanced DMEM/F12 培養(yǎng)基。
關(guān)鍵添加劑(增殖期): N2 補(bǔ)充劑、重組人堿性成纖維細(xì)胞生長因子 (bFGF) 以及四環(huán)素或強(qiáng)力霉素(用于維持 v-myc 表達(dá))。
包被要求: 培養(yǎng)皿必須使用 多聚鳥氨酸 (Poly-L-ornithine) 和 纖連蛋白 (Fibronectin) 進(jìn)行預(yù)包被。
培養(yǎng)環(huán)境: 37 攝氏度,5% $CO_2$
分化誘導(dǎo): 移除 bFGF 并添加四環(huán)素(關(guān)閉 v-myc)、cAMP 和 GDNF,誘導(dǎo) 6-10 天。
3. 細(xì)胞應(yīng)用
疾病建模: 利用 MPP+ 或 6-OHDA 誘導(dǎo)損傷,模擬帕金森病神經(jīng)元變性。
神經(jīng)毒理學(xué): 評估環(huán)境毒素或化學(xué)品對人源神經(jīng)元的發(fā)育毒性。
多巴胺研究: 探索多巴胺轉(zhuǎn)運(yùn)體 (DAT) 功能及突觸傳遞機(jī)制。
4. 注意事項(xiàng)
包被質(zhì)量: LUHMES 細(xì)胞對貼壁要求極高,包被不均勻會(huì)導(dǎo)致細(xì)胞分化失敗或成團(tuán)脫落。
血清限制: 建議使用無血清培養(yǎng)體系,以保持其神經(jīng)前體特性并控制分化方向。
English Datasheet
1. General Product Information
Product Name: BioVector? LUHMES Human Mesencephalic Precursor Cell Line
Tissue Source: Human Embryonic Mesencephalon
Growth Properties: Adherent (Requires coating)
Differentiation Potential: Efficiently differentiates into mature dopaminergic neurons (TH-positive).
Morphology: Bipolar or small polygonal in proliferative phase; extensive neurite outgrowth post-differentiation.
2. Culture Conditions
Basal Medium: BioVector? Advanced DMEM/F12 Medium.
Key Supplements (Proliferation): N2 supplement, recombinant human bFGF, and Tetracycline/Doxycycline (to maintain v-myc expression).
Surface Coating: Plates must be pre-coated with Poly-L-ornithine and Fibronectin.
Incubation: 37 degrees Celsius, 5% $CO_2$.
Differentiation Protocol: Removal of bFGF and addition of Tetracycline (to shut down v-myc), cAMP, and GDNF for 6–10 days.
3. Applications
Disease Modeling: Simulating Parkinson's disease-associated neurodegeneration using MPP+ or 6-OHDA.
Neurotoxicology: Assessing the developmental or acute neurotoxicity of environmental toxins on human-derived neurons.
Dopaminergic Biology: Investigating Dopamine Transporter (DAT) kinetics and synaptogenesis.
4. Key Usage Notes
Coating Consistency: LUHMES cells are highly sensitive to the substrate; inconsistent coating leads to poor attachment and failed neuronal maturation.
Serum-Free Requirement: BioVector? recommends strictly serum-free conditions to prevent uncontrolled differentiation and maintain the integrity of the precursor pool.
注意 / Note: BioVector? LUHMES 細(xì)胞系應(yīng)在生物安全二級 (BSL-2) 條件下操作。分化后的神經(jīng)元為終末分化狀態(tài),不再具有增殖能力,因此實(shí)驗(yàn)設(shè)計(jì)需精確計(jì)算初始接種密度。
BioVector? LUHMES should be handled under Biosafety Level 2 (BSL-2). Differentiated neurons are post-mitotic and cannot be subcultured; precise initial seeding density is critical for successful experimental design.


BioVector NTCC質(zhì)粒載體菌株細(xì)胞蛋白抗體基因保藏中心
E-mail: [email protected]
http://www.nedfriskphoto.com
您正在向 biovector.net 發(fā)送關(guān)于產(chǎn)品 LUHMES 人多巴胺能神經(jīng)元前體細(xì)胞系 / BioVector? LUHMES Human Dopaminergic Neuronal Precursor Cell Line 的詢問
- 公告/新聞




